Jacobi Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-124
| Closed | -$12K | – | 1486 |
|
|
2021
Q2 | $12K | Buy |
124
+36
| +41% | +$3.48K | ﹤0.01% | 983 |
|
|
2021
Q1 | $9K | Buy |
88
+61
| +226% | +$6.24K | ﹤0.01% | 1002 |
|
|
2020
Q4 | $3K | Buy |
27
+11
| +69% | +$1.22K | ﹤0.01% | 1114 |
|
|
2020
Q3 | $2K | Buy |
16
+9
| +129% | +$1.13K | ﹤0.01% | 1105 |
|
|
2020
Q2 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 1158 |
|